BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30975166)

  • 21. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
    Wu H; Zhang J; Dai R; Xu J; Feng H
    J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
    Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
    Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
    Hong Q; Fang J; Pang Y; Zheng J
    Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: implication in tumor progression and prognosis.
    Abd El-Rehim DM; Osman NA
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):1-9. PubMed ID: 25481287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.
    Yin K; Liao Q; He H; Zhong D
    Med Oncol; 2012 Dec; 29(5):3449-55. PubMed ID: 22847601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
    Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
    Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
    Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
    Liu Y; Sun X; Huo C; Sun C; Zhu J
    Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.
    Li Z; Liao Q; Wu Y; Liao M; Hao Y; Zhang S; Song S; Li B; Zhang YD
    Pathol Oncol Res; 2012 Jul; 18(3):657-61. PubMed ID: 22215309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
    Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
    BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.
    Tong D; Liang YN; Stepanova AA; Liu Y; Li X; Wang L; Zhang F; Vasilyeva NV
    Tumour Biol; 2017 Feb; 39(2):1010428317691010. PubMed ID: 28215104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
    Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.